A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Nathalia Leal e NAGAI, Maria Aparecida e FURUYA, Tatiane Katsue. Modulação da expressâo gênica e epignética. Oncologia - da molécula à clínica. Tradução . São Paulo: Editora dos Editores, 2022. . . Acesso em: 19 abr. 2024.
APA
Santos, N. L., Nagai, M. A., & Furuya, T. K. (2022). Modulação da expressâo gênica e epignética. In Oncologia - da molécula à clínica. São Paulo: Editora dos Editores.
NLM
Santos NL, Nagai MA, Furuya TK. Modulação da expressâo gênica e epignética. In: Oncologia - da molécula à clínica. São Paulo: Editora dos Editores; 2022. [citado 2024 abr. 19 ]
Vancouver
Santos NL, Nagai MA, Furuya TK. Modulação da expressâo gênica e epignética. In: Oncologia - da molécula à clínica. São Paulo: Editora dos Editores; 2022. [citado 2024 abr. 19 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO-RUGOLO, Juliana et al. Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer. Human pathology, v. 83, p. 177-191, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.humpath.2018.08.026. Acesso em: 19 abr. 2024.
APA
Machado-rugolo, J., Fabro, A. T., Ascheri, D., Farhat, C., Ab'saber, A. M., Sa, V. K. de, et al. (2019). Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer. Human pathology, 83, 177-191. doi:10.1016/j.humpath.2018.08.026
NLM
Machado-rugolo J, Fabro AT, Ascheri D, Farhat C, Ab'saber AM, Sa VK de, Nagai MA, Takagaki T, Terra R, Parra ER, Capelozzi VL. Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer [Internet]. Human pathology. 2019 ; 83 177-191.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.humpath.2018.08.026
Vancouver
Machado-rugolo J, Fabro AT, Ascheri D, Farhat C, Ab'saber AM, Sa VK de, Nagai MA, Takagaki T, Terra R, Parra ER, Capelozzi VL. Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer [Internet]. Human pathology. 2019 ; 83 177-191.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.humpath.2018.08.026
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALCANTARA FILHO, Paulo R. de et al. Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC). Breast cancer management, v. 7, n. 2, 2018Tradução . . Disponível em: https://doi.org/10.2217/bmt-2017-0019. Acesso em: 19 abr. 2024.
APA
Alcantara Filho, P. R. de, Mangone, F. R., Pavanelli, A. C., Garcia, S. A. de B., Nonogaki, S., Andrade, V. P. D., & Nagai, M. A. (2018). Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC). Breast cancer management, 7( 2). doi:10.2217/bmt-2017-0019
NLM
Alcantara Filho PR de, Mangone FR, Pavanelli AC, Garcia SA de B, Nonogaki S, Andrade VPD, Nagai MA. Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC) [Internet]. Breast cancer management. 2018 ; 7( 2):[citado 2024 abr. 19 ] Available from: https://doi.org/10.2217/bmt-2017-0019
Vancouver
Alcantara Filho PR de, Mangone FR, Pavanelli AC, Garcia SA de B, Nonogaki S, Andrade VPD, Nagai MA. Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC) [Internet]. Breast cancer management. 2018 ; 7( 2):[citado 2024 abr. 19 ] Available from: https://doi.org/10.2217/bmt-2017-0019
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARLINI, Maria Jose et al. Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands. Bmc cancer, v. 18, 2018Tradução . . Disponível em: https://doi.org/10.1186/s12885-018-4550-z. Acesso em: 19 abr. 2024.
APA
Carlini, M. J., Nagai, M. A., Recouvreix, M. S., & Simian, M. (2018). Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands. Bmc cancer, 18. doi:10.1186/s12885-018-4550-z
NLM
Carlini MJ, Nagai MA, Recouvreix MS, Simian M. Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands [Internet]. Bmc cancer. 2018 ; 18[citado 2024 abr. 19 ] Available from: https://doi.org/10.1186/s12885-018-4550-z
Vancouver
Carlini MJ, Nagai MA, Recouvreix MS, Simian M. Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands [Internet]. Bmc cancer. 2018 ; 18[citado 2024 abr. 19 ] Available from: https://doi.org/10.1186/s12885-018-4550-z
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONATTO, Naieli et al. PHLDA1 (pleckstrin homology-like domain, family A, member 1) knockdown promotes migration and invasion of MCF10A breast epithelial cells. Cell adhesion & migration, v. 12, n. 1, p. 37-46, 2018Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/25547. Acesso em: 19 abr. 2024.
APA
Bonatto, N., Carlini, M. J., Garcia, S. A. de B., & Nagai, M. A. (2018). PHLDA1 (pleckstrin homology-like domain, family A, member 1) knockdown promotes migration and invasion of MCF10A breast epithelial cells. Cell adhesion & migration, 12( 1), 37-46. doi:10.1080/19336918.2017.1313382
NLM
Bonatto N, Carlini MJ, Garcia SA de B, Nagai MA. PHLDA1 (pleckstrin homology-like domain, family A, member 1) knockdown promotes migration and invasion of MCF10A breast epithelial cells [Internet]. Cell adhesion & migration. 2018 ; 12( 1): 37-46.[citado 2024 abr. 19 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25547
Vancouver
Bonatto N, Carlini MJ, Garcia SA de B, Nagai MA. PHLDA1 (pleckstrin homology-like domain, family A, member 1) knockdown promotes migration and invasion of MCF10A breast epithelial cells [Internet]. Cell adhesion & migration. 2018 ; 12( 1): 37-46.[citado 2024 abr. 19 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25547
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Juliana et al. Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S. Acesso em: 19 abr. 2024. , 2017
APA
Machado, J., Nagai, M. A., Fabro, A. T., & Capelozzi, V. L. (2017). Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
NLM
Machado J, Nagai MA, Fabro AT, Capelozzi VL. Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S955.[citado 2024 abr. 19 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
Vancouver
Machado J, Nagai MA, Fabro AT, Capelozzi VL. Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S955.[citado 2024 abr. 19 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA FILHO, Lourival A. e CARLINI, Maria José e NAGAI, Maria Aparecida. Role of cellular and extracellular Par-4 expression in tumor formation and drug sensitivity. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445. Acesso em: 19 abr. 2024. , 2017
APA
Oliveira Filho, L. A., Carlini, M. J., & Nagai, M. A. (2017). Role of cellular and extracellular Par-4 expression in tumor formation and drug sensitivity. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. doi:10.1158/1538-7445
NLM
Oliveira Filho LA, Carlini MJ, Nagai MA. Role of cellular and extracellular Par-4 expression in tumor formation and drug sensitivity [Internet]. Cancer Research. 2017 ; 77( 6):[citado 2024 abr. 19 ] Available from: https://doi.org/10.1158/1538-7445
Vancouver
Oliveira Filho LA, Carlini MJ, Nagai MA. Role of cellular and extracellular Par-4 expression in tumor formation and drug sensitivity [Internet]. Cancer Research. 2017 ; 77( 6):[citado 2024 abr. 19 ] Available from: https://doi.org/10.1158/1538-7445
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARCIA, Simone Aparecida de Bessa et al. Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity. International Journal of Molecular Medicine, v. 39, n. 4, p. 809-818, 2017Tradução . . Disponível em: https://doi.org/10.3892/ijmm.2017.2900. Acesso em: 19 abr. 2024.
APA
Garcia, S. A. de B., Pavanelli, A. C., Melo, N. C. e, & Nagai, M. A. (2017). Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity. International Journal of Molecular Medicine, 39( 4), 809-818. doi:10.3892/ijmm.2017.2900
NLM
Garcia SA de B, Pavanelli AC, Melo NC e, Nagai MA. Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity [Internet]. International Journal of Molecular Medicine. 2017 ; 39( 4): 809-818.[citado 2024 abr. 19 ] Available from: https://doi.org/10.3892/ijmm.2017.2900
Vancouver
Garcia SA de B, Pavanelli AC, Melo NC e, Nagai MA. Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity [Internet]. International Journal of Molecular Medicine. 2017 ; 39( 4): 809-818.[citado 2024 abr. 19 ] Available from: https://doi.org/10.3892/ijmm.2017.2900
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Elisa Napolitano et al. Linear mRNA amplification approach for RNAseq from limited amount of RNA. Gene, v. 564, n. 2, p. 220-227, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.gene.2015.03.058. Acesso em: 19 abr. 2024.
APA
Ferreira, E. N., Molina, G. de C., Puga, R. D., Nagai, M. A., Campos, A. H. J. F. M., Guimarães, G. C., et al. (2015). Linear mRNA amplification approach for RNAseq from limited amount of RNA. Gene, 564( 2), 220-227. doi:10.1016/j.gene.2015.03.058
NLM
Ferreira EN, Molina G de C, Puga RD, Nagai MA, Campos AHJFM, Guimarães GC, Nunes DN, Pasqualini R, Arap W, Brentani H, Dias-Neto E, Brentani RR, Carraro DM. Linear mRNA amplification approach for RNAseq from limited amount of RNA [Internet]. Gene. 2015 ; 564( 2): 220-227.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.gene.2015.03.058
Vancouver
Ferreira EN, Molina G de C, Puga RD, Nagai MA, Campos AHJFM, Guimarães GC, Nunes DN, Pasqualini R, Arap W, Brentani H, Dias-Neto E, Brentani RR, Carraro DM. Linear mRNA amplification approach for RNAseq from limited amount of RNA [Internet]. Gene. 2015 ; 564( 2): 220-227.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.gene.2015.03.058
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARRARA, G. F. A. et al. Ipsilateral breast cancer recurrence in conservative treatment for locally advanced breast cancer. The Breast. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S0960-9776(15)70240-7. Acesso em: 19 abr. 2024. , 2015
APA
Carrara, G. F. A., Neto, C. S., Abrão-Machado, L. F., Nunes, J. S., Folgueira, M. A. A. K., Brentani, M. M., & Vieira, R. A. C. (2015). Ipsilateral breast cancer recurrence in conservative treatment for locally advanced breast cancer. The Breast. New York: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/S0960-9776(15)70240-7
NLM
Carrara GFA, Neto CS, Abrão-Machado LF, Nunes JS, Folgueira MAAK, Brentani MM, Vieira RAC. Ipsilateral breast cancer recurrence in conservative treatment for locally advanced breast cancer [Internet]. The Breast. 2015 ; 24( supl. 1): S96.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/S0960-9776(15)70240-7
Vancouver
Carrara GFA, Neto CS, Abrão-Machado LF, Nunes JS, Folgueira MAAK, Brentani MM, Vieira RAC. Ipsilateral breast cancer recurrence in conservative treatment for locally advanced breast cancer [Internet]. The Breast. 2015 ; 24( supl. 1): S96.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/S0960-9776(15)70240-7
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANGONE, Flavia Rotea et al. ATM gene mutations in sporadic breast cancer patients from Brazil. Springer Plus, v. 4, 2015Tradução . . Disponível em: https://doi.org/10.1186/s40064-015-0787-z. Acesso em: 19 abr. 2024.
APA
Mangone, F. R., Miracca, E. C., Feilotter, H. E., Mulligan, L. M., & Nagai, M. A. (2015). ATM gene mutations in sporadic breast cancer patients from Brazil. Springer Plus, 4. doi:10.1186/s40064-015-0787-z
NLM
Mangone FR, Miracca EC, Feilotter HE, Mulligan LM, Nagai MA. ATM gene mutations in sporadic breast cancer patients from Brazil [Internet]. Springer Plus. 2015 ; 4[citado 2024 abr. 19 ] Available from: https://doi.org/10.1186/s40064-015-0787-z
Vancouver
Mangone FR, Miracca EC, Feilotter HE, Mulligan LM, Nagai MA. ATM gene mutations in sporadic breast cancer patients from Brazil [Internet]. Springer Plus. 2015 ; 4[citado 2024 abr. 19 ] Available from: https://doi.org/10.1186/s40064-015-0787-z
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONZAGA, Ana Denise Gomes et al. Hydroxymethylbilane Synthase Gene Mutations and Polymorphisms in Brazilian Families with Acute Intermittent Porphyria. Annals of Human Genetics, v. 79, n. 3, p. 162-172, 2015Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/ahg.12102/epdf. Acesso em: 19 abr. 2024.
APA
Gonzaga, A. D. G., Amorim, L. M. da F. de, Fonseca, A. B. M., Nogueira, T. L. S., Pereira, O. M. D., Nagai, M. A., et al. (2015). Hydroxymethylbilane Synthase Gene Mutations and Polymorphisms in Brazilian Families with Acute Intermittent Porphyria. Annals of Human Genetics, 79( 3), 162-172. doi:10.1111/ahg.12102
NLM
Gonzaga ADG, Amorim LM da F de, Fonseca ABM, Nogueira TLS, Pereira OMD, Nagai MA, Barretto OC de O, Ribeiro GS. Hydroxymethylbilane Synthase Gene Mutations and Polymorphisms in Brazilian Families with Acute Intermittent Porphyria [Internet]. Annals of Human Genetics. 2015 ; 79( 3): 162-172.[citado 2024 abr. 19 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/ahg.12102/epdf
Vancouver
Gonzaga ADG, Amorim LM da F de, Fonseca ABM, Nogueira TLS, Pereira OMD, Nagai MA, Barretto OC de O, Ribeiro GS. Hydroxymethylbilane Synthase Gene Mutations and Polymorphisms in Brazilian Families with Acute Intermittent Porphyria [Internet]. Annals of Human Genetics. 2015 ; 79( 3): 162-172.[citado 2024 abr. 19 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/ahg.12102/epdf
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAIS, J. et al. Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.clinexprheumatol.org/article.asp?a=8201. Acesso em: 19 abr. 2024. , 2014
APA
Morais, J., Martin, P., Velosa, A. P. P., Andrade, P. C., Cruz, I. B., Miracca, E. C., et al. (2014). Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.clinexprheumatol.org/article.asp?a=8201
NLM
Morais J, Martin P, Velosa APP, Andrade PC, Cruz IB, Miracca EC, Barrence FAC, Carrasco S, Goldeinstein-Schainberg C, Nagai MA, Parra ER, Capelozzi VL, Teodoro WR. Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-66-S67.[citado 2024 abr. 19 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8201
Vancouver
Morais J, Martin P, Velosa APP, Andrade PC, Cruz IB, Miracca EC, Barrence FAC, Carrasco S, Goldeinstein-Schainberg C, Nagai MA, Parra ER, Capelozzi VL, Teodoro WR. Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-66-S67.[citado 2024 abr. 19 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8201
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Vanessa Morais et al. Decreased expression of ADAMTS-1 in human breast tumors stimulates migration and invasion. Molecular Cancer, v. 12, n. 2, p. 15 , 2013Tradução . . Disponível em: https://doi.org/10.1186/1476-4598-12-2. Acesso em: 19 abr. 2024.
APA
Freitas, V. M., Amaral, J. B. do, Silva, T. A., Santos, E. de S., Mangone, F. R., Pinheiro, J. de J., et al. (2013). Decreased expression of ADAMTS-1 in human breast tumors stimulates migration and invasion. Molecular Cancer, 12( 2), 15 . doi:10.1186/1476-4598-12-2
NLM
Freitas VM, Amaral JB do, Silva TA, Santos E de S, Mangone FR, Pinheiro J de J, Jaeger RG, Nagai MA, Machado-Santelli GM. Decreased expression of ADAMTS-1 in human breast tumors stimulates migration and invasion [Internet]. Molecular Cancer. 2013 ; 12( 2): 15 .[citado 2024 abr. 19 ] Available from: https://doi.org/10.1186/1476-4598-12-2
Vancouver
Freitas VM, Amaral JB do, Silva TA, Santos E de S, Mangone FR, Pinheiro J de J, Jaeger RG, Nagai MA, Machado-Santelli GM. Decreased expression of ADAMTS-1 in human breast tumors stimulates migration and invasion [Internet]. Molecular Cancer. 2013 ; 12( 2): 15 .[citado 2024 abr. 19 ] Available from: https://doi.org/10.1186/1476-4598-12-2
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RADIN, Adriano et al. Preparation of new [[99mTc](MeOBzEN)(H2O)(CO)3]+ complexes and in vitro evaluation as potential tumor diagnostic radiopharmaceutical. Journal of labelled compounds and radiopharmaceuticals. Sussex (GB): Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/jlcr.3058/pdf. Acesso em: 19 abr. 2024. , 2013
APA
Radin, A., Marques, F. L. N., Nagai, M. A., & Buchpiguel, C. A. (2013). Preparation of new [[99mTc](MeOBzEN)(H2O)(CO)3]+ complexes and in vitro evaluation as potential tumor diagnostic radiopharmaceutical. Journal of labelled compounds and radiopharmaceuticals. Sussex (GB): Faculdade de Medicina, Universidade de São Paulo. doi:10.1002/jlcr.3058
NLM
Radin A, Marques FLN, Nagai MA, Buchpiguel CA. Preparation of new [[99mTc](MeOBzEN)(H2O)(CO)3]+ complexes and in vitro evaluation as potential tumor diagnostic radiopharmaceutical [Internet]. Journal of labelled compounds and radiopharmaceuticals. 2013 ; 56 S410.[citado 2024 abr. 19 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/jlcr.3058/pdf
Vancouver
Radin A, Marques FLN, Nagai MA, Buchpiguel CA. Preparation of new [[99mTc](MeOBzEN)(H2O)(CO)3]+ complexes and in vitro evaluation as potential tumor diagnostic radiopharmaceutical [Internet]. Journal of labelled compounds and radiopharmaceuticals. 2013 ; 56 S410.[citado 2024 abr. 19 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/jlcr.3058/pdf
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASOLARI, Debora A. et al. Insulin-like growth factor-1 and 17β-estradiol down-regulate prostate apoptosis response-4 expression in MCF-7 breast cancer cells. International Journal of Molecular Medicine, v. 28, n. 3, p. 337-342, 2012Tradução . . Disponível em: http://www.spandidos-publications.com/10.3892/ijmm.2011.691. Acesso em: 19 abr. 2024.
APA
Casolari, D. A., Pereira, M. C., Garcia, S. A. de B., & Nagai, M. A. (2012). Insulin-like growth factor-1 and 17β-estradiol down-regulate prostate apoptosis response-4 expression in MCF-7 breast cancer cells. International Journal of Molecular Medicine, 28( 3), 337-342. doi:10.3892/ijmm.2011.691
NLM
Casolari DA, Pereira MC, Garcia SA de B, Nagai MA. Insulin-like growth factor-1 and 17β-estradiol down-regulate prostate apoptosis response-4 expression in MCF-7 breast cancer cells [Internet]. International Journal of Molecular Medicine. 2012 ; 28( 3): 337-342.[citado 2024 abr. 19 ] Available from: http://www.spandidos-publications.com/10.3892/ijmm.2011.691
Vancouver
Casolari DA, Pereira MC, Garcia SA de B, Nagai MA. Insulin-like growth factor-1 and 17β-estradiol down-regulate prostate apoptosis response-4 expression in MCF-7 breast cancer cells [Internet]. International Journal of Molecular Medicine. 2012 ; 28( 3): 337-342.[citado 2024 abr. 19 ] Available from: http://www.spandidos-publications.com/10.3892/ijmm.2011.691
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANGONE, Flavia R et al. PIK3CA exon 20 mutations are associated with poor prognosis in breast cancer patients. Clinics, v. 67, n. 11, p. 1285-1290, 2012Tradução . . Disponível em: https://doi.org/10.6061/clinics/2012(11)11. Acesso em: 19 abr. 2024.
APA
Mangone, F. R., Bobrovnitchaia, I. G., Salaorni, S., Manuli, E., & Nagai, M. A. (2012). PIK3CA exon 20 mutations are associated with poor prognosis in breast cancer patients. Clinics, 67( 11), 1285-1290. doi:10.6061/clinics/2012(11)11
NLM
Mangone FR, Bobrovnitchaia IG, Salaorni S, Manuli E, Nagai MA. PIK3CA exon 20 mutations are associated with poor prognosis in breast cancer patients [Internet]. Clinics. 2012 ; 67( 11): 1285-1290.[citado 2024 abr. 19 ] Available from: https://doi.org/10.6061/clinics/2012(11)11
Vancouver
Mangone FR, Bobrovnitchaia IG, Salaorni S, Manuli E, Nagai MA. PIK3CA exon 20 mutations are associated with poor prognosis in breast cancer patients [Internet]. Clinics. 2012 ; 67( 11): 1285-1290.[citado 2024 abr. 19 ] Available from: https://doi.org/10.6061/clinics/2012(11)11
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARCIA, Simone A. de Bessa e PEREIRA, Michelly C. e NAGAI, Maria A. Expression Pattern of the Pro-apoptotic Gene PAR-4 During the Morphogenesis of MCF-10A Human Mammary Epithelial Cells. Cancer Microenvironment, v. 4, n. 1, p. 33-38, 2011Tradução . . Disponível em: http://link.springer.com/article/10.1007%2Fs12307-010-0059-y. Acesso em: 19 abr. 2024.
APA
Garcia, S. A. de B., Pereira, M. C., & Nagai, M. A. (2011). Expression Pattern of the Pro-apoptotic Gene PAR-4 During the Morphogenesis of MCF-10A Human Mammary Epithelial Cells. Cancer Microenvironment, 4( 1), 33-38. doi:10.1007/s12307-0100059-y
NLM
Garcia SA de B, Pereira MC, Nagai MA. Expression Pattern of the Pro-apoptotic Gene PAR-4 During the Morphogenesis of MCF-10A Human Mammary Epithelial Cells [Internet]. Cancer Microenvironment. 2011 ; 4( 1): 33-38.[citado 2024 abr. 19 ] Available from: http://link.springer.com/article/10.1007%2Fs12307-010-0059-y
Vancouver
Garcia SA de B, Pereira MC, Nagai MA. Expression Pattern of the Pro-apoptotic Gene PAR-4 During the Morphogenesis of MCF-10A Human Mammary Epithelial Cells [Internet]. Cancer Microenvironment. 2011 ; 4( 1): 33-38.[citado 2024 abr. 19 ] Available from: http://link.springer.com/article/10.1007%2Fs12307-010-0059-y
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARCIA, S. A. B. e NAGAI, M. A. Transcriptional regulation of bidirectional gene pairs by 17β-estradiol in MCF-7 breast cancer cells. Brazilian journal of medical and biological research, v. 44, n. 2, p. 112-122, 2011Tradução . . Disponível em: https://doi.org/10.1590/S0100-879X2010007500149. Acesso em: 19 abr. 2024.
APA
Garcia, S. A. B., & Nagai, M. A. (2011). Transcriptional regulation of bidirectional gene pairs by 17β-estradiol in MCF-7 breast cancer cells. Brazilian journal of medical and biological research, 44( 2), 112-122. doi:10.1590/S0100-879X2010007500149
NLM
Garcia SAB, Nagai MA. Transcriptional regulation of bidirectional gene pairs by 17β-estradiol in MCF-7 breast cancer cells [Internet]. Brazilian journal of medical and biological research. 2011 ; 44( 2): 112-122.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1590/S0100-879X2010007500149
Vancouver
Garcia SAB, Nagai MA. Transcriptional regulation of bidirectional gene pairs by 17β-estradiol in MCF-7 breast cancer cells [Internet]. Brazilian journal of medical and biological research. 2011 ; 44( 2): 112-122.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1590/S0100-879X2010007500149